Skip to main content

FDA-ASPHO Pediatric Hematology/Oncology Educational Program

Advance Your Expertise in Pediatric Hematology/Oncology Drug Development and Regulatory Review

FDA Logo 225The US Food and Drug Administration (FDA) and ASPHO have partnered to cosponsor an 8-month educational program designed for early career pediatric hematology/oncology clinicians and researchers. This program addresses a critical gap in training by providing learners with a thorough understanding of pediatric hematology/oncology drug-development and the regulatory review process.

Applicants will have an opportunity to shape the content of the program, but the curriculum includes the following foundational topics:

  • Pediatric hematology/oncology drug regulation
  • The Investigational New Drug (IND), New Drug Application (NDA), and Biologic License Application (BLA) processes
  • Expedited drug development pathways
  • Early phase clinical trials
  • Clinical trial design and efficacy endpoint considerations
  • Pediatric hematology/oncology disease-specific considerations (eg, clinical practice, biomarker development, etc.)

Program Highlights

  • Duration: 8 months
  • Format
    • One full-day, in-person kick-off session in conjunction with the ASPHO Conference April 29, 2026, in Minneapolis, MN
    • 40 hours of virtual, synchronous learning conducted monthly through January 2027
    • Each virtual session will include brief didactics, large group discussion, breakout sessions, and case discussions of approved hematology & oncology drugs
  • Cost: Free! Participants also receive 50% off ASPHO Conference registration
  • Cohort Size: Limited to 20 participants

Eligibility

  • Current ASPHO membership sustained for the duration of the program
  • Pediatric hematology/oncology early career clinicians and researchers—3rd-year fellows through 10 years post-fellowship
  • Commitment to attend the in-person session in Minneapolis, April 29, 2026, and all virtual meetings for the duration of the 8-month program
  • International applicants welcome (must meet visa requirements for in-person session at time of application)

Participant Expectations

  • Active participation in all sessions
  • Pre-reading and brief assignments (~1–1.5 hours per session)
  • Camera on for virtual sessions

Apply Now!
Application Deadline: Monday, December 29, 2025, 3 pm CT

Application Requirements

  • Online application form
  • Curriculum vitae
  • Letter of support from program director (3rd year fellow applicants only)
  • Attestation of ability to participate fully in the program

The FDA and ASPHO welcome applications from young investigators and/or clinicians for this prestigious program. It is ASPHO's goal to ensure diverse geographic, demographic, and specialty representation in all its programming selection.

Download Program Flyer (PDF)

Contact
For questions, please email This email address is being protected from spambots. You need JavaScript enabled to view it. .